Kenya to produce its own vaccines beginning 2027

Kenya will begin to produce its own vaccines in 2027. The Kenya BioVax Institute says it will be ready to roll out the production in the next 1 year, marking a historic step toward vaccine self-reliance. The new facility, a joint venture between the World Bank and the Kenya Government, will manufacture and commercialise human vaccines and health technologies, positioning Kenya as a regional hub for medical innovation. Connect with KBC Online; Subscribe to our channel: https://t.ly/86BKNc Follow us on Twitter: https://twitter.om/KBCChannel1 Find us on Facebook: https://www.facebook.com/kbcchannel1TV Check our website: https://www.kbc.co.ke/ #kbcchannel1 #news #kbclive